“I’m honored and humbled by the support and confidence that Julie, Tony, and our entire organization have given me from day one,” said Dr. Canner will be responsible for leading the research and development of new innovations aimed at improving the telehealth and direct-to-consumer testing experience for healthcare providers, their patients, and individuals wishing to have more agency over their own health. Especially, when it comes to improving the health of our communities and others we serve.” “He has scored remarkable wins for the company as we’ve grown within our market and continues to push us towards excellence in all we do. “JP’s new role as Chief Scientific Officer is a pivotal one as we continue our mission of improving the health and well-being of individuals through advancements in diagnostics,” said Julie Brazil, COO, and Co-founder of G360. “Our company would not be where it is today were it not for his clinical expertise and innovative mindset.”Ĭanner received his bachelor's and master's degrees from Boston University and earned his doctoral degree from Tufts University Graduate School of Biomedical Sciences.Īfter his postdoctoral research fellowship at Emory University working on stem cell activation and muscle regeneration, he transitioned to clinical laboratory medicine and received his board certification in toxicology. “We’re so excited to have JP serve as our Chief Scientific Officer,” said G360 CEO and Co-founder, Anthony Remington. Since joining the G360 group of companies in 2018, Canner has been a key figure in the growth of Gravity Diagnostics and the nascent Gravity+ and is responsible for overseeing the development of molecular testing for disease detection and diagnosis. Canner has over 20 years of molecular biology experience ranging from mouse models of cardiovascular disease to clinical laboratory assay development. Until recently, he served as the company’s Vice President of Regulatory, Clinical, and Research Programs and its Laboratory Director.ĭr. to serve as the company’s Chief Scientific Officer. 15, 2022 (GLOBE NEWSWIRE) - G360, the parent company of both Gravity Diagnostics and Gravity+, has promoted Dr.
0 Comments
Leave a Reply. |